Nantahala Capital Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Nantahala Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $2.34 Million - $5.86 Million	-238,945 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $1.59 Million - $2.13 Million	-188,765 Reduced 44.13%	238,945 $2.27 Million
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $1.31 Million - $2.08 Million	-174,000 Reduced 28.92%	427,710 $3.79 Million
Q3 2018 Nov 14, 2018	SELL	$11.25 - $17.7 $2.51 Million - $3.95 Million	-223,290 Reduced 27.07%	601,710 $6.77 Million
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $10.3 Million - $14 Million	825,000 New	825,000 $10.6 Million

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.